Physician

Racquel D Innis-Shelton, MD

According to 2025 Medicare claims, Racquel Innis-Shelton, MD (NPI: 1356553408) practices hematopoietic cell transplantation and cellular therapy in the Birmingham, AL market, with the plurality of this provider's patient population coming from Shelby, AL. This provider's primary affiliated billing organization is BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (NPI: 1841216389; TIN: 522170293) and primary practice location at 35007-8703. Innis-Shelton is affiliated with the Alabama Physician Network, LLC (ACO ID: A3738), participating under the MSSP model.

Innis-Shelton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 109,547 HCPCS/CPT codes, and received $1,639,682 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,722 prescription claims across 358 beneficiaries totaling $3,820,715 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 12 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $36,641 to $1,639,682. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,708 to $3,820,715. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.